Miglitol: Assessment of its Role in the Treatment of Patients with Diabetes Mellitus

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

1993 • 23,535 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Arzneimittelforschung

2005 • 8,820 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

1998 • 8,603 citations

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

1998 • 7,971 citations

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

1998 • 4,159 citations

Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated Type 2 diabetes mellitus

1998 • 144 citations

Advantages of α-Glucosidase Inhibition as Monotherapy in Elderly Type 2 Diabetic Patients

1998 • 129 citations

The Efficacy and Safety of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone

1997 • 114 citations

Effects of the Carbohydrase Inhibitor Miglitol in Sulfonylurea-Treated NIDDM Patients

1994 • 111 citations

The effect of miglitol and acarbose after an oral glucose load: a novel hypoglycaemic mechanism?

1990 • 92 citations

Pharmacokinetics of miglitol. Absorption, distribution, metabolism, and excretion following administration to rats, dogs, and man.

1997 • 70 citations

The antiglycogenolytic action of 1‐deoxynojirimycin results from a specific inhibition of the α‐1,6‐glucosidase activity of the debranching enzyme

1989 • 59 citations

The Effect of Acarbose and Miglitol (BAY-M-1099) on Postprandial Glucose Levels Following Ingestion of Various Sources of Starch by Nondiabetic and Streptozotocin-Induced Diabetic Rats

1989 • 58 citations

Effects of 8-Wk α-Glucosidase Inhibition on Metabolic Control, C-Peptide Secretion, Hepatic Glucose Output, and Peripheral Insulin Sensitivity in Poorly Controlled Type II Diabetic Patients

1989 • 53 citations

Chronic Treatment of African-American Type 2 Diabetic Patients With β-Glucosidase Inhibition

1998 • 48 citations

Comparison of miglitol and glibenclamide in diet-treated type 2 diabetic patients.

1995 • 47 citations

Miglitol may have a blood glucose lowering effect unrelated to inhibition of alpha-glucosidase

1987 • 43 citations

α-Glucosidase Inhibition by Miglitol in NIDDM Patients

1992 • 36 citations

Regulation of the absorption of dietary carbohydrate in man by two new glycosidase inhibitors.

1986 • 34 citations

Long-Term Titrated-Dose α-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients

1998 • 33 citations

Effects of α-Glucosidase Inhibition on Meal Glucose Tolerance and Timing of Insulin Administration in Patients With Type I Diabetes Mellitus

1991 • 32 citations

Effects of alpha-glucosidase inhibitors on mouth to caecum transit time in humans.

1992 • 29 citations

Does Suppression of Postprandial Blood Glucose Excursions by the α-Glucosidase Inhibitor Miglitol Improve Insulin Sensitivity in Diet-Treated Type II Diabetic Patients?

1996 • 29 citations

Effects of BAYm 1099, New α-Glucosidase Inhibitor, on Acute Metabolic Responses and Metabolic Control in NIDDM Over 1 Mo

1988 • 28 citations

Effects of the?-glucosidase inhibitor 1 desoxynojirimycin (BAY M 1099) on postprandial blood glucose, serum insulin and C-peptide levels in type II diabetic patients

1986 • 27 citations

Effect of an alpha-glucosidase inhibitor (BAY m 1099) on post-prandial blood glucose and insulin in type II diabetics

1986 • 24 citations

Reduction of postprandial blood glucose by theα-glucosidase inhibitor Miglitol (BAY m 1099) in Type II diabetes

1989 • 22 citations

Effect of α-glycohydrolase inhibitors (Bay m1099 and Bay o1248) on sucrose metabolism in normal men

1986 • 22 citations

A double-blind study on the efficacy and tolerance of a new alpha-glucosidase inhibitor in type-2 diabetics.

1986 • 22 citations

Postprandial Glycemic Control, Hormonal Effects and Carbohydrate Malabsorption during Long-Term Administration of the Alpha-Glucosidase Inhibitor Miglitol

1990 • 21 citations

EFFECT OF MIGLITOL AND ACARBOSE ON STARCH DIGESTION, DAILY PLASMA GLUCOSE PROFILES AND CATARACT FORMATION

1993 • 18 citations

Effect of Miglitol (Bay m1099), a new alpha-glucosidase inhibitor, on glucose, insulin, C-peptide and GIP responses to an oral sucrose load in patients with post-prandial hypoglycaemic symptoms.

1991 • 16 citations

Efficacy and tolerability of miglitol in the treatment of patients with non—insulin-dependent diabetes mellitus

1995 • 16 citations

Metabolic consequences of the alpha-glucosidase inhibitor BAY-M-1099 given to nondiabetic and diabetic rats fed a high-carbohydrate diet

1989 • 15 citations

Inhibition of Glycemic and Hormonal Responses after Repetitive Sucrose and Starch Loads by Different Doses of the α-Glucosidase Inhibitor Miglitol (BAY m 1099) in Man

1991 • 13 citations

Study of the effect of miglitol on the pharmacokinetics and pharmacodynamics of warfarin in healthy males.

1996 • 13 citations

The effects of the intestinal glucosidase inhibitor BAY M 1099 (miglitol) on glycemic status of obese-diabetic rats

1993 • 13 citations

Effect of miglitol (BAY m-1099) on fasting blood glucose in type 2 diabetes mellitus.

1994 • 11 citations

Miglitol (Bay m 1099) has no extraintestinal effects on glucose control in healthy volunteers

1996 • 10 citations

Effect of the alpha-glucosidase inhibitor N-hydroxyethyl-1-deoxynojirimycin (bay M 1099) on the biosynthesis of liver secretory glycoproteins

1989 • 9 citations

THE EFFECT OF TWO NEW α‐GLUCOSIDASE INHIBITORS ON METABOLIC RESPONSES TO A MIXED MEAL IN NORMAL VOLUNTEERS

1987 • 5 citations

A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus

1987 • 4 citations